drugset / Trial / NCT00790985

Efficacy of Flavocoxid 500 mg Compared With Naproxen 500 mg in Subjects With Moderate-severe Osteoarthritis of the Knee

NCT00790985

Completed 223 enrolled Primus Pharmaceuticals
RandomizedParallel-groupTriple-blindTreatment

Summary

To compare flavocoxid with naproxen for patients with moderate to severe osteoarthritis of the knee.

Timeline

Start
2008-01
Primary completion
2008-08
Completion
2008-08

Drugs

EvaluationDrugModalityDoseRoute
Comparator Naproxen Small molecule 500 mg
Subject flavocoxid Other / unclassified 500 mg

Indications